Skip to main content

Table 2 KOOS

From: Intra-articular injection of bone marrow aspirate concentrate (BMAC) or adipose-derived stem cells (ADSCs) for knee osteoarthritis: a prospective comparative clinical trial

 

BMAC (N = 51)

ADSCs (N = 51)

BMAC versus ADSCs (p valuec)

KOOS symptomsa

 Before

55.23 ± 15.94

52.73 ± 15.04

0.4167

 1 month

77.47 ± 14

73.24 ± 9.8

0.081

 6 months

84.13 ± 18.35

85.91 ± 16.77

0.6095

 p valueb

 < 0.0001

 < 0.0001

 

KOOS paina

 Before

46.52 ± 17.73

44.23 ± 7

0.3929

 1 month

73.07 ± 16.34

73.27 ± 10.12

0.94

 6 months

93.60 ± 9.23

95.91 ± 6.16

0.1405

 p valueb

 < 0.0001

 < 0.0001

 

KOOS functionala

 Before

47.14 ± 17

50.6 ± 9.62

0.2099

 1 month

76.97 ± 15.15

80.1 ± 12.56

0.2599

 6 months

81.87 ± 22.68

89.24 ± 16

0.0606

 p valueb

 < 0.0001

 < 0.0001

 

KOOS sporta

 Before

27.25 ± 21.19

22.15 ± 11.28

0.13

 1 month

59.50 ± 19.65

58.52 ± 11.71

0.7602

 6 months

68.82 ± 35.42

60.58 ± 17.16

0.1383

 p valueb

 < 0.0001

 < 0.0001

 

KOOS QoLa

 Before

30.83 ± 12.52

22.62 ± 4.51

0.0001

 1 month

60 ± 20.94

59.34 ± 10.28

0.8166

 6 months

69.36 ± 26.87

65.44 ± 19.7

0.4027

 p valueb

 < 0.0001

 < 0.0001

 
  1. KOOS Knee Injury and Osteoarthritis Outcome Score, QoL Quality of Life
  2. aData was expressed by mean ± standard deviation
  3. bp value is calculated between before and 6-month results
  4. cThe p value is calculated between the BMAC group results and the ADSCs group results